Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | XDH | P47989 | 6/20 | 0.38 |
| ▸ | NEK2 | P51955 | 1/20 | 0.37 |
| ▸ | PLK1 | P53350 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.35 |
| ▸ | MYC | P01106 | 1/20 | 0.35 |
| ▸ | IDE | P14735 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11515732 | 0.91 | NEK2 (0.41) | L3MBTL1RXFP1XDHNEK2PLK1 | |
| SCHEMBL11663142 | 0.91 | NEK2 (0.41) | L3MBTL1RXFP1XDHNEK2PLK1 | |
| SCHEMBL11515662 | 0.77 | POLB (0.40) | L3MBTL1RXFP1XDHPOLBATM | |
| SCHEMBL11515178 | 0.77 | POLB (0.40) | L3MBTL1RXFP1XDHPOLBATM | |
| SCHEMBL13726855 | 0.77 | L3MBTL1 (0.51) | L3MBTL1RXFP1POLBATMLMNA | |
| SCHEMBL11517082 | 0.73 | POLB (0.54) | L3MBTL1RXFP1POLBATMLMNA | |
| SCHEMBL11517079 | 0.73 | POLB (0.54) | L3MBTL1RXFP1POLBATMLMNA | |
| SCHEMBL11515582 | 0.73 | POLB (0.41) | L3MBTL1RXFP1POLBATMLMNA | |
| SCHEMBL11516769 | 0.72 | RECQL (0.38) | L3MBTL1RXFP1XDHNEK2PLK1 | |
| SCHEMBL29961369 | 0.68 | SCN9A (0.47) | XDHKDM4EMAP4K4MYC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE30024-E | ANTIALLERGENS | STERLING DRUG INC. (US) | 1979-06-05 | — | — | US | disclosed |